Healthy Skepticism Library item: 2552
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Mintzes B.
2001 Aug;
http://www.chspr.ubc.ca//hpru/pdf/dtca-v2-litreview.pdf
Abstract:
The conclusion of this review is that conclusion, many gaps remain in the research evidence on outcomes of prescription drug advertising to the public. No reliable evidence exists to support hypotheses of potential health benefits or to exclude potential harm. In 1991, when the US GAO reviewed the literature on DTCA, there was little experience with this form of advertising. In the intervening 10 years, the amount of public exposure to DTCA has grown enormously. However, knowledge of DTCA’s effects on health and on the quality of health care services remains elusive.
Keywords:
*systematic review
United States
New Zealand
Canada
DTCA
direct-to-consumer advertising
quality of prescribing
safety & risk information
quality of information
doctor-patient relationship
print advertisements
broadcast advertisements
consumer behaviour & knowledge
EVALUATION OF PROMOTION: DIRECT-TO-CONSUMER ADVERTISING
INFLUENCE OF PROMOTION: CONSUMER DRUG COSTS
INFLUENCE OF PROMOTION: DOCTOR-PATIENT RELATIONSHIP
INFLUENCE OF PROMOTION: PRESCRIBING, DRUG USE
VOLUME OF AND EXPENDITURE ON PROMOTION
